Definium Therapeutics (DFTX) Change in Cash (2019 - 2026)
Definium Therapeutics (DFTX) reported Change in Cash of $4.7 million for Q1 2026, up 102.45% year-over-year from $2.3 million in Q1 2025, and down 98.03% quarter-over-quarter from $237.9 million in Q4 2025.
Definium Therapeutics (DFTX) Change in Cash (2019 - 2026) Analysis & Trends
Definium Therapeutics (DFTX) has 7 years of Change in Cash data on file, last reported at $4.7 million in Q1 2026.
- Change in Cash for Q1 2026 came in at $4.7 million, up 102.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $179.7 million (up 206.01% YoY), and the FY2025 annual result was -$15.9 million, down 109.14% from the prior year.
- Change in Cash eased to $4.7 million in Q1 2026 per DFTX's latest filing, from $237.9 million in the prior quarter.
- Over five years, Change in Cash peaked at $237.9 million in Q4 2025 and troughed at -$190.9 million in Q1 2025.
- A 5-year average of $7.6 million and a median of -$12.5 million in 2023 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2024 and 2025: Change in Cash soared 6386.57% in 2024, then slumped 437.63% in 2025.
- A 5-year view of Change in Cash shows it stood at -$12.4 million in 2022, then slumped by 45.39% to -$18.0 million in 2023, then declined by 19.72% to -$21.5 million in 2024, then surged by 1204.2% to $237.9 million in 2025, then tumbled by 98.03% to $4.7 million in 2026.
- Business Quant data shows DFTX's Change in Cash at $4.7 million in Q1 2026, $237.9 million in Q4 2025, and -$13.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -45.97 Mn |
| 10 | Definium Therapeutics | 2.46 Bn | 2.09 Bn | - | 4.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.68 Mn |
| Dec 31, 2025 | 237.88 Mn |
| Sep 30, 2025 | -13.43 Mn |
| Jun 30, 2025 | -49.46 Mn |
| Mar 31, 2025 | -190.89 Mn |
| Dec 31, 2024 | -21.54 Mn |
| Sep 30, 2024 | 52.15 Mn |
| Jun 30, 2024 | -9.20 Mn |
| Mar 31, 2024 | 152.63 Mn |
| Dec 31, 2023 | -18.00 Mn |
| Sep 30, 2023 | 804,000.00 |
| Jun 30, 2023 | -12.51 Mn |
| Mar 31, 2023 | -12.73 Mn |
| Dec 31, 2022 | -12.38 Mn |
| Sep 30, 2022 | 48.78 Mn |
| Jun 30, 2022 | -14.73 Mn |
| Mar 31, 2022 | -13.07 Mn |
| Dec 31, 2021 | -12.38 Mn |
| Sep 30, 2021 | -11.18 Mn |
| Jun 30, 2021 | -2.94 Mn |